Headline News

 

FDA approves Otarmeni the first gene therapy for genetic hearing loss as Regeneron commits to offering it for free

Posted on April 28, 2026

Regeneron strikes deal with white house to cut drug prices, offers gene therapy for free

Posted on April 28, 2026

Etavopivat meets co-primary endpoints in phase 3 HIBISCUS trial for sickle cell disease

Posted on April 21, 2026

Abbott presents new data on Cancerguard multi cancer early detection test at AACR 2026

Posted on April 21, 2026

FDA to convene expert panel to review restrictions on popular peptides

Posted on April 21, 2026

Nuvaxovid demonstrates superior tolerability over mRNA vaccine in head to head study

Posted on April 21, 2026

Tozorakimab meets primary endpoint in Phase III MIRANDA trial for COPD

Posted on April 21, 2026

Ultomiris meets primary endpoint in I CAN phase III trial for IgA nephropathy

Posted on April 21, 2026

FDA grants priority review to Padcev and Keytruda for muscle invasive bladder cancer

Posted on April 21, 2026

Blenrep approved in China for 2L+ relapsed or refractory multiple myeloma

Posted on April 21, 2026

Lilly’s oral GLP 1 Foundayo hits primary endpoint in landmark ACHIEVE 4 cardiovascular trial

Posted on April 21, 2026

Eli Lilly set to acquire Kelonia Therapeutics in $7 billion genomic medicine play

Posted on April 21, 2026

AbbVie presents compelling ovarian cancer data that could significantly expand ELAHERE’s market reach

Posted on April 14, 2026

Novo Nordisk secures EU regulatory approval to streamline Wegovy distribution, paving way for broader home delivery

Posted on April 14, 2026

Novo Nordisk partners with OpenAI to accelerate drug discovery

Posted on April 14, 2026